respiratori
physiolog
respiratori
tract
suscept
diseas
uniqu
alter
gynecolog
obstetr
condit
includ
normal
pregnanc
chapter
summar
normal
physiolog
alter
pregnanc
consid
patholog
diseas
disord
aris
pregnanc
airway
disord
infecti
diseas
pulmonari
vascular
embol
disord
acut
lung
injuri
discuss
final
pleural
parenchym
diseas
aris
consequ
gynecolog
condit
address
profound
alter
respiratori
function
cardiovascular
physiolog
accompani
normal
pregnanc
healthi
women
condit
contribut
mani
disord
lung
pregnanc
adapt
chang
gravid
period
design
support
matern
fetal
wellb
special
stress
fetal
growth
parturit
may
exacerb
underli
disord
confus
interpret
laboratori
imag
studi
use
assess
mani
common
condit
upper
airway
particularli
nasal
mucos
edema
common
normal
pregnanc
gravid
women
complain
rhiniti
symptom
attribut
least
partial
placent
growth
hormon
effect
mucos
congest
symptom
begin
first
trimest
persist
throughout
gestat
mani
patient
thought
rhiniti
pregnanc
may
actual
coincid
caus
rhiniti
import
implic
nasal
mucos
edema
pregnanc
predispos
noseble
includ
nasal
intub
oral
approach
favor
intub
requir
time
deliveri
chest
wall
configur
also
alter
partial
due
increas
averag
costal
angl
partial
due
increas
circumfer
lower
chest
wall
diaphragmat
posit
elev
cm
excurs
diminish
muscl
strength
measur
maximum
transdiaphragmat
pressur
appear
diminish
usual
mean
valu
cm
h
allow
reserv
augment
minut
ventil
normal
pregnanc
stress
deliveri
import
chang
take
place
lung
function
lung
volum
loss
lung
volum
result
elev
diaphragm
partial
offset
increas
chest
wall
diamet
therefor
function
residu
capac
frc
diminish
ml
reduct
frc
compris
equal
reduct
expiratori
reserv
volum
residu
volum
loss
frc
term
made
wors
recumb
diaphragm
elev
greatest
higher
intraabdomin
pressur
increas
pulmonari
blood
volum
pregnanc
may
also
serv
lower
frc
reduct
frc
associ
clinic
increas
uptak
elimin
inhal
anesthet
rapid
desatur
hypopnea
result
loss
oxygen
reservoir
function
endexpiratori
lung
volum
endotrach
intub
term
thu
substanti
hazard
nongravid
patient
airway
function
larg
unchang
pregnanc
airway
resist
may
actual
decreas
slightli
routin
measur
air
flow
fev
flow
rate
midexpiratori
lung
volum
forc
expiratori
flow
fvc
fef
thu
valuabl
assess
dyspnea
pregnanc
strike
chang
respiratori
drive
minut
ventil
central
drive
assess
inspiratori
pressur
measur
msec
airway
occlus
onset
inspir
p
increas
week
continu
increas
week
gestat
return
normal
week
deliveri
serial
chang
respiratori
drive
appear
correl
chang
serum
progesteron
level
carbon
dioxid
product
increas
one
third
one
half
last
trimest
made
greatli
augment
ventil
primari
respiratori
alkalosi
renal
output
reach
week
gestat
week
heart
rate
increas
well
less
stroke
volum
chang
well
effect
supin
versu
later
posit
depict
figur
gravid
newli
postpartum
patient
may
develop
pregnancyspecif
disord
also
continu
experi
common
disord
aris
outsid
pregnanc
natur
histori
frequenc
coexist
disord
sometim
alter
gravid
state
even
diseas
alter
pregnanc
manag
requir
special
knowledg
safeti
therapi
specif
diseas
consid
principl
mind
asthma
affect
gener
popul
common
pulmonari
disord
pregnanc
work
group
asthma
pregnanc
nation
asthma
educ
prevent
program
naepp
estim
pregnanc
complic
asthma
matern
asthma
increas
risk
preeclampsia
preterm
birth
infant
low
birth
weight
intrauterin
growth
restrict
congenit
malform
perinat
death
studi
examin
hormon
milieu
suggest
progesteron
might
diminish
smooth
muscl
contractil
lung
uteru
gut
junip
bicarbon
wast
compens
normal
find
arteri
blood
ga
measur
typic
show
ph
rang
pco
reach
low
mm
hg
po
rise
slightli
result
increas
alveolar
ventil
increas
minut
ventil
due
increas
tidal
volum
respiratori
rate
unchang
earli
rise
later
pregnanc
oxygen
consumpt
increas
pregnanc
owe
matern
fetal
metabol
demand
chang
paramet
shown
figur
adapt
cardiovascular
chang
design
support
matern
fetal
circul
contribut
risk
hydrostat
pulmonari
edema
accordingli
cardiac
disord
pregnanc
often
present
respiratori
failur
normal
pregnanc
matern
blood
volum
increas
l
red
blood
cell
mass
increas
well
account
normal
decreas
hematocrit
plasma
oncot
pressur
also
drop
intravascular
volum
expand
increas
risk
pulmonari
edema
lower
intravascular
hydrostat
pressur
hour
parturit
oncot
pressur
fall
blood
loss
mobil
extravascular
fluid
enlarg
intravascular
volum
pregnanc
accommod
chiefli
venou
capacit
vessel
central
venou
pressur
pulmonari
capillari
occlus
wedg
pressur
unchang
reflect
increas
left
ventricular
complianc
evidenc
enlarg
cardiac
silhouett
seen
chest
radiograph
increas
left
ventricular
enddiastol
volum
result
augment
stroke
volum
eject
fraction
littl
chang
system
vascular
resist
svr
diminish
chang
account
increas
cardiac
indic
accept
safeti
profil
fetu
also
safe
use
lactat
nonselect
epinephrin
carri
risk
uterin
vasoconstrict
anim
model
probabl
best
avoid
accept
agonist
pregnanc
includ
metaproterenol
albuterol
pirbuterol
bitolterol
terbutalin
toxicolog
pharmacolog
longact
salmeterol
formoterol
expect
similar
shorteract
agonist
drug
recommend
patient
poor
control
combin
inhal
longact
corticosteroid
shortact
limit
data
suggest
drug
safe
pregnanc
theophyllin
also
long
histori
use
pregnanc
consid
safe
therapeut
rang
plasma
lower
diminish
protein
bind
pregnanc
theophyllin
pass
freeli
fetu
newborn
occasion
show
sign
theophyllin
toxic
particularli
matern
blood
level
high
theophyllin
also
transmit
breast
milk
milktoserum
ratio
gener
less
matern
dose
transfer
infant
anim
studi
suggest
leukotrien
inhibitor
montelukast
zafirlukast
safe
pregnanc
continu
patient
previous
respond
zileuton
avoid
anim
studi
rais
question
safeti
pregnanc
anim
studi
shown
increas
incid
cleft
palat
use
corticosteroid
limit
human
data
support
associ
estim
excess
risk
use
first
trimest
system
corticosteroid
also
report
caus
intrauterin
growth
restrict
rel
modest
degre
halogen
corticosteroid
cross
placenta
easili
fetal
neonat
adren
suppress
major
concern
compound
overal
riskbenefit
consider
nonetheless
favor
use
persist
sever
asthma
exacerb
unrespons
measur
one
studi
suggest
higher
dose
inhal
corticosteroid
ie
beclomethason
mcgday
may
associ
small
increas
risk
congenit
abnorm
although
confound
effect
increas
asthma
sever
exclud
limit
data
confirm
safeti
newer
inhal
costicosteroid
tabl
summar
us
food
drug
administr
fda
safeti
classif
agent
use
treatment
asthma
pregnanc
labor
deliveri
especi
hazard
asthmat
patient
partli
drug
commonli
administ
narcot
fentanyl
releas
histamin
may
worsen
bronchospasm
lumbar
epidur
analgesia
gener
prefer
gener
anesthesia
use
pretreat
atropin
glycopyrrol
assist
bronchodil
ketamin
prefer
anesthet
although
halogen
anesthet
low
concentr
may
provid
bronchodil
well
preterm
labor
may
safe
treat
nifedipin
magnesium
sulfat
oxytocin
optim
labor
induct
agent
use
postpartum
hemorrhag
prostaglandin
f
methylergonovin
ergonovin
may
caus
bronchospasm
avoid
possibl
colleagu
perform
serial
measur
bronchial
reactiv
methacholin
challeng
women
pregnanc
found
decreas
airway
hyperrespons
clinic
epidemiolog
studi
howev
fail
provid
convinc
evid
consist
chang
natur
histori
asthma
pregnanc
turner
cowork
exampl
compil
result
nine
studi
asthma
symptom
report
pregnant
women
among
report
worsen
report
improv
report
chang
studi
report
similar
figur
worsen
improv
exhibit
chang
differ
report
natur
histori
probabl
reflect
differ
studi
popul
smoke
histori
ethnic
variabl
fetal
matern
outcom
asthma
pregnanc
also
examin
varieti
studi
sinc
advers
outcom
includ
increas
incid
preterm
labor
low
neonat
birth
weight
increas
perinat
mortal
preeclampsia
vagin
hemorrhag
chronic
hypertens
complic
labor
report
larg
epidemiolog
studi
sweden
confirm
associ
asthma
perinat
mortal
low
birth
weight
nonetheless
adequ
therapi
tailor
diseas
sever
associ
good
outcom
therapi
asthma
pregnanc
individu
accord
sever
diseas
frequenc
symptom
outlin
naepp
object
measur
lung
volum
flow
part
regimen
initi
offic
spirometri
recommend
home
peak
flow
monitor
consid
women
asthma
attack
labor
fetal
monitor
consid
essenti
naepp
therapi
base
step
approach
mild
intermitt
asthma
best
manag
inhal
shortact
agonist
symptomat
relief
asthma
caus
occasion
symptom
treat
daili
antiinflammatori
therapi
prefer
choic
inhal
corticosteroid
budesonid
best
studi
henc
prefer
although
substant
safeti
data
exist
beclomethason
well
altern
therapi
includ
cromolyn
sustainedreleas
theophyllin
leukotrien
antagonist
frequent
need
shortact
agonist
prompt
institut
increas
use
antiinflammatori
agent
treat
rather
mask
deterior
clinic
cours
longact
use
concurr
longact
inhal
corticosteroid
final
addit
rapidli
taper
cours
oral
corticosteroid
consid
acut
sever
asthma
patient
activ
symptom
alreadi
use
inhal
steroid
daili
alternateday
oral
steroid
administr
eg
prednison
mgday
sometim
requir
extens
practic
algorithm
made
avail
naepp
work
group
asthma
pregnanc
larg
bodi
literatur
examin
topic
possibl
teratogen
agent
use
pharmacotherapi
asthma
pregnanc
gener
risk
poorli
control
asthma
far
outweigh
possibl
hazard
drug
therapi
anim
human
studi
agonist
administ
either
inhal
system
strate
good
matern
neonat
outcom
women
cf
prematur
deliveri
common
women
wors
baselin
fev
gestat
diabet
common
larg
us
review
gravid
women
cf
enrol
us
cystic
fibrosi
foundat
nation
patient
registri
surviv
actual
better
gravid
group
match
control
patient
cf
women
cf
becam
pregnant
higher
predict
percentag
fev
higher
weight
pregnanc
clearli
harm
subgroup
sever
adjust
age
pseudomona
aeruginosa
colon
pancreat
function
fev
anoth
casecontrol
studi
pregnanc
littl
effect
patient
stabl
cf
although
poor
outcom
seen
sever
diseas
might
anticip
studi
suggest
risk
stratifi
accord
sever
ill
declin
pulmonari
function
tend
mirror
severityadjust
control
subject
clearli
cf
patient
requir
substanti
care
visit
physician
pregnant
prepregn
counsel
particularli
women
sever
diseas
essenti
limit
excess
matern
fetal
risk
pneumonia
lead
caus
matern
fetal
morbid
mortal
matern
mortal
pneumonia
nonimmunocompromis
host
rang
seri
publish
sinc
report
incid
vari
wide
per
deliveri
may
higher
gener
popul
one
report
howev
indic
pneumonia
may
increas
incid
human
immunodefici
viru
hiv
infect
chronic
diseas
major
risk
factor
postpartum
pneumonia
may
develop
first
week
deliveri
common
cesarean
section
pregnanc
increas
risk
major
complic
pneumonia
seri
mading
colleagu
patient
cull
deliveri
suffer
major
complic
includ
five
intub
two
empyema
one
pneumothorax
one
pericardi
tamponad
similarli
seri
brigg
associ
patient
requir
mechan
ventil
die
pneumonia
sever
index
psi
use
identifi
sever
pneumonia
hospit
admiss
appear
perform
well
obstetr
popul
underestim
need
hospit
admiss
pneumonia
increas
risk
preterm
labor
smallforgestationalag
rate
high
intrauterin
neonat
death
rate
rang
seri
underli
chronic
ill
mother
power
predictor
advers
outcom
fetu
mother
pneumonia
pregnanc
commonli
bacteri
origin
microbiolog
spectrum
mirror
communityacquir
pneumonia
streptococcu
pneumonia
haemophilu
influenza
common
organ
common
organ
includ
mycoplasma
pneumonia
chlamydia
pneumonia
communityacquir
cystic
fibrosi
cf
present
white
black
common
genet
diseas
improv
therapi
median
surviv
increas
year
femal
cf
patient
age
may
pregnant
time
despit
frequent
infertil
women
due
delay
sexual
develop
pregnanc
cf
patient
might
anticip
associ
advers
fetal
matern
outcom
sever
recent
small
case
seri
demon
within
hour
suscept
pregnant
women
expos
varicella
administr
varizig
reduc
abolish
risk
fetal
infect
congenit
varicella
syndrom
effect
prevent
complic
varicella
mother
patient
evalu
similarli
adult
decis
made
administ
immun
globulin
basi
immun
statu
type
exposur
health
statu
current
licens
attenu
live
vaccin
varicella
contraind
pregnanc
sever
acut
respiratori
syndrom
sar
due
novel
coronaviru
hucovsar
caus
pneumonia
acut
respiratori
distress
syndrom
ard
respiratori
failur
patient
mortal
rate
although
data
limit
pregnant
women
appear
wors
nonpregn
patient
four
seven
patient
requir
ventilatori
support
one
seri
sar
infect
advers
affect
pregnanc
miscarriag
fetal
distress
intrauterin
death
report
presum
relat
hypoxemia
fungal
pneumonia
uncommon
pregnanc
although
evid
blastomycosi
histoplasmosi
sever
pregnanc
appear
coccidioidomycosi
like
dissemin
pregnanc
southwestern
unit
state
pregnanc
complic
coccidioid
immiti
see
efig
dissemin
highli
probabl
third
trimest
relat
subtl
impair
cellmedi
immun
stimulatori
effect
progesteron
fungal
prolifer
amphotericin
accept
therapi
dissemin
coccidioidomycosi
azol
administ
first
trimest
associ
branchial
cleft
abnorm
use
deliveri
tuberculosi
appear
common
sever
pregnanc
howev
present
may
atyp
diseas
often
extrapulmonari
diagnosi
may
delay
reluct
perform
appropri
imag
studi
pregnanc
alter
reactiv
tuberculin
skin
test
henc
test
perform
recommend
group
pregnanc
assay
also
accept
mean
test
tubercul
infect
see
chapter
asymptomat
patient
posit
skin
test
chest
radiograph
defer
week
gestat
symptomat
patient
posit
skin
test
merit
chest
radiograph
regardless
gestat
stage
isoniazid
rifampin
ethambutol
accept
safeti
profil
pregnanc
part
standard
treatment
regimen
advis
cdc
american
thorac
societi
pregnant
women
less
collect
experi
pyrazinamid
drug
recommend
use
pregnanc
world
health
organ
worldwid
data
accumul
pyrazinamid
appear
emerg
drug
consid
treat
multidrugresist
tuberculosi
hivinfect
women
streptomycin
contrast
clearli
associ
congenit
deaf
contraind
pregnanc
pneumonia
caus
agent
identifi
half
case
unfortun
diagnosi
pneumonia
frequent
delay
reluct
obtain
chest
radiograph
posteroanterior
radiograph
perform
grid
peak
voltag
kv
expos
mother
mrad
fetu
time
less
later
chest
radiograph
produc
greater
matern
exposur
mrad
usual
requir
hazard
fetu
mother
delay
diagnosi
greatli
exce
risk
small
radiat
dose
antibacteri
therapi
similar
treatment
nonpregn
patient
although
tetracyclin
quinolon
metronidazol
avoid
possibl
erythromycin
azithromycin
antibiot
prefer
favor
safeti
profil
see
tabl
viral
pneumonia
remain
seriou
concern
pregnanc
influenza
pandem
matern
rate
mortal
pneumonia
high
epidem
pregnant
women
account
fatal
half
women
childbear
age
die
pregnant
sinc
matern
mortal
rate
influenza
b
pneumonia
rel
low
still
much
higher
gener
popul
center
diseas
control
prevent
cdc
recommend
inactiv
influenza
vaccin
otherwis
healthi
women
second
third
trimest
pregnanc
although
influenza
viru
cross
placenta
current
opinion
hold
like
teratogen
fetu
despit
isol
report
link
influenza
neural
tube
malform
amantadin
use
pregnanc
success
treatment
prophylaxi
although
case
report
cardiovascular
defect
note
firsttrimest
use
consider
influenza
viral
resist
drug
spring
previous
unrecogn
strain
influenza
viru
emerg
quickli
spread
around
world
report
clinic
experi
larg
number
hospit
patient
influenza
australianew
zealand
throughout
unit
state
confirm
pregnanc
confer
high
risk
seriou
diseas
appreci
mortal
earli
treatment
pregnant
women
women
week
postpartum
oseltamivir
zanamivir
appear
benefici
pregnant
women
also
strongli
urg
vaccin
monoval
inactiv
inject
vaccinenot
live
attenu
vaccin
varicella
pneumonia
caus
viru
dna
herpesviru
group
also
link
particularli
advers
outcom
pregnanc
haak
cowork
report
increas
incid
pneumon
pregnant
women
primari
varicella
infect
mortal
rate
group
time
period
date
back
compar
adult
data
conflict
prospect
studi
confirm
increas
incid
mortal
pregnanc
treatment
acyclovir
appear
reduc
mortal
gravid
patient
use
therapi
activ
diseas
use
varicellazost
immun
globulin
varizig
consid
gravid
women
special
risk
pulmonari
edema
varieti
reason
includ
hypervolemia
high
cardiac
output
pregnanc
occasion
need
tocolyt
drug
affect
vascular
bed
uniqu
vascular
endotheli
disord
pregnanc
among
effect
noteworthi
colloid
osmot
pressur
diminish
pregnanc
although
effect
transcapillari
pressur
gradient
partial
offset
decreas
interstiti
fluid
colloid
osmot
pressur
explain
chapter
etiolog
underli
cardiac
diseas
use
tocolyt
drug
fluid
overload
preeclampsia
common
caus
acut
pulmonari
edema
pregnanc
cardiovascular
adapt
pregnanc
alreadi
summar
effect
underli
cardiac
disord
predict
stenot
valvular
lesion
particularli
poorli
toler
mitral
stenosi
common
symptomat
valvular
diseas
pregnanc
frequent
present
pulmonari
edema
gestat
also
immedi
postpartum
larg
shift
intravascular
volum
associ
deliveri
gradient
across
stenot
mitral
valv
augment
increas
blood
volum
cardiac
output
heart
rate
take
place
gestat
puerperium
aortic
stenosi
increas
cardiac
output
requir
pregnanc
worsen
gradient
across
valv
compensatori
mechan
left
ventricular
enddiastol
volum
increas
low
svr
impair
coronari
arteri
fill
diastol
precipit
ischem
syndrom
reduct
svr
pregnanc
mitig
consequ
mitral
aortic
regurgit
lefttoright
intracardiac
shunt
endocardi
cushion
defect
worsen
consequ
eisenmeng
syndrom
uncorrect
tetralog
fallot
depend
cardiac
disord
perturb
induc
pregnanc
alter
fraction
shunt
induc
hypoxemia
precipit
pulmonari
edema
special
problem
pregnanc
peripartum
cardiomyopathi
disord
develop
deliveri
may
present
congest
heart
failur
associ
special
propens
pulmonari
system
embol
last
month
pregnanc
month
thereaft
standard
therapi
heart
failur
includ
diuret
angiotensinconvert
enzym
inhibitor
blocker
usual
effect
sometim
implant
defibril
even
left
ventricular
assist
devic
heart
transplant
requir
use
drug
sympathomimet
agent
retard
prematur
labor
uncommon
current
obstetr
practic
past
associ
incid
pulmonari
edema
etiolog
disord
controversi
like
multifactori
natur
relat
myocardi
effect
vascular
permeabl
impair
fluid
retent
usual
present
least
hour
therapi
rel
acut
onset
dyspnea
pulmonari
edema
seen
chest
radiograph
simpl
discontinu
therapi
often
result
rapid
improv
whether
diuret
need
given
unresolv
furosemid
usual
administ
pulmonari
edema
also
complic
tocolysi
perform
calcium
channel
blocker
patient
preeclampsia
eclampsia
develop
pulmonari
edema
spectrum
hemodynam
find
associ
pregnancyinduc
hypertens
preeclampsia
wide
gener
left
ventricular
preload
normal
low
afterload
high
cardiac
output
normal
low
fig
systol
diastol
function
may
also
impair
pulmonari
edema
commonli
first
present
postpartum
period
reflect
fluid
administr
deliveri
low
colloid
oncot
pressur
abnorm
vascular
permeabl
like
contribut
well
hemodynam
monitor
patient
probabl
warrant
oliguria
complic
pictur
pulmonari
embol
lead
caus
matern
mortal
account
pregnancyrel
death
larg
health
care
deliveri
system
unit
state
even
though
risk
venou
thromboembol
pregnant
women
five
time
great
agematch
sexmatch
nongravid
control
still
rel
infrequ
danish
populationbas
studi
deliveri
found
cumul
incid
deliveri
studi
incid
detect
venou
thromboembol
increas
deliveri
introduct
ultrasonographi
demonstr
report
incid
may
depend
adequaci
diagnost
procedur
employ
studi
report
rate
per
pregnanc
risk
thrombosi
increas
pregnanc
partli
increas
coagul
factor
particularli
v
viii
x
von
willebrand
factor
antigen
partli
mark
fall
protein
venou
stasi
import
contributor
thrombosi
caus
uterin
compress
inferior
vena
cava
left
iliac
vein
local
trauma
pelvic
vein
time
deliveri
probabl
account
peak
incid
thromboembol
postpartum
period
especi
cesarean
section
specif
risk
factor
thromboembol
includ
previou
thromboembol
pregnanc
take
oral
contracept
prolong
bed
rest
complic
cesarean
deliveri
age
thrombophilia
obes
smoke
inherit
defect
includ
defici
antithrombin
protein
protein
c
factor
v
leiden
prothrombin
antiphospholipid
syndrom
acquir
thrombophilia
previou
thromboembol
antithrombin
defici
warrant
prophylact
heparin
administr
throughout
pregnanc
commonli
accomplish
lowmolecularweight
heparin
lmwh
due
safeti
decreas
risk
heparininduc
osteopenia
thrombocytopenia
mrad
procedur
limit
role
pregnanc
level
exposur
believ
caus
teratogen
associ
exposur
greater
cgi
rad
howev
increas
incid
childhood
leukemia
document
lower
fetal
radiat
exposur
rang
cgi
rad
comparison
lung
scintigraphi
pulmonari
ct
angiographi
conclud
former
method
accur
latter
diagnos
pulmonari
embol
pregnanc
ventilationperfus
scan
pregnanc
due
patient
younger
age
lack
comorbid
associ
lower
incid
intermedi
scan
higher
rate
normal
scan
ct
angiographi
may
often
technic
suboptim
due
increas
cardiac
output
pregnanc
magnet
reson
imag
mri
gadolinium
contrast
also
promis
imag
pelvic
lower
extrem
vein
well
pulmonari
arteri
littl
contrastassoci
toxic
widespread
use
requir
increas
avail
ultrafast
scanner
evalu
accuraci
venou
thromboembol
pregnanc
treat
heparin
warfarin
cross
placenta
caus
nasal
ophthalmolog
central
nervou
system
abnorm
fetu
lmwh
appear
safe
pregnanc
compar
unfraction
heparin
associ
fewer
advers
effect
lmwh
prefer
unfraction
heparin
pregnanc
use
weightadjust
dose
regimen
weight
gain
pregnanc
make
formula
dose
less
reliabl
author
also
clinic
diagnosi
deep
venou
thrombosi
pregnanc
puerperium
even
difficult
nonpregn
patient
peripher
edema
associ
pregnanc
asymmetr
compress
leftsid
common
iliac
vein
gravid
uteru
initi
diagnost
test
duplex
ultrasonographi
combin
realtim
bmode
compress
ultrasonographi
plu
doppler
venou
ultrasonographi
patient
high
clinic
suspicion
neg
test
repeat
examin
day
may
valuabl
venou
thrombosi
lower
extrem
document
usual
left
side
case
report
chan
colleagu
diagnosi
pulmonari
embol
pregnant
women
rel
straightforward
ventilationperfus
scan
comput
tomographi
ct
pulmonari
angiographi
perform
pregnanc
modifi
fashion
estim
fetal
radiat
exposur
perfus
scan
cgi
mrad
simpli
halv
perfus
dose
standard
practic
pregnanc
without
greatli
impair
resolut
need
ventil
portion
studi
perfus
normal
ct
pulmonari
angiographi
accept
imag
modal
associ
similarli
low
radiat
dose
fetu
fig
howev
risk
consid
potenti
carcinogen
effect
radiat
exposur
mother
breast
although
shield
reduc
exposur
see
fig
pulmonari
angiographi
perform
brachial
rout
expos
fetu
cgi
small
amount
amniot
fluid
may
enter
circul
uncompl
pregnanc
rare
caus
catastroph
syndrom
amniot
fluid
embol
report
incid
vari
per
pregnanc
variat
larg
depend
method
case
identif
onset
usual
labor
deliveri
immedi
uterin
manipul
develop
sever
dyspnea
hypoxemia
seizur
cardiovascular
collaps
arrest
patient
surviv
initi
insult
dissemin
intravascular
coagul
ard
usual
superven
risk
factor
includ
older
matern
age
induct
labor
high
pariti
cesarean
section
low
uterin
segment
lacer
meconium
stain
amniot
fluid
abruptio
placenta
present
case
fetal
demis
matern
mortal
rate
high
recent
report
suggest
mortal
overal
amniot
fluid
embol
may
account
matern
death
us
registri
case
patient
amniot
fluid
embol
ruptur
membran
sever
undergon
intrauterin
procedur
clearli
implic
traumat
open
uterin
vessel
pathogenesi
exact
quantiti
constitu
amniot
fluid
requir
initi
syndrom
unknown
patholog
fetal
squamou
cell
found
matern
pulmonari
circul
autopsi
fig
even
symptomfre
patient
fetal
cell
may
aspir
pulmonari
arteri
cathet
place
reason
hemodynam
process
often
biphas
pulmonari
hypertens
initi
follow
left
ventricular
failur
chang
may
caus
leukotrien
arachidon
acid
metabolit
particularli
prostaglandin
f
appear
amniot
fluid
labor
immunolog
basi
chang
seem
like
women
male
fetus
like
acquir
disord
clark
associ
seiz
similar
anaphylaxi
suggest
disord
renam
advoc
titrat
dose
achiev
antifactor
x
level
unitsml
hour
inject
howev
lack
good
data
lack
correl
level
efficaci
complic
make
routin
monitor
difficult
justifi
lmwh
treatment
usual
given
least
week
postpartum
minimum
total
durat
therapi
month
lmwh
held
hour
induct
cesarean
section
neuraxi
anesthesia
twicedaili
dose
dose
morn
deliveri
daili
dose
regimen
postpartum
warfarin
given
safe
lactat
thrombolyt
therapi
use
success
lifethreaten
thromboembol
pregnanc
complic
rate
similar
nonpregn
women
figur
dosereduct
method
chest
ct
pregnant
patient
scout
view
ct
acquisit
show
intern
barium
shield
arrow
creat
patient
swallow
dilut
mixtur
barium
water
sever
minut
ct
scan
barium
distribut
within
stomach
proxim
small
bowel
attenu
intern
matern
radiat
may
otherwis
expos
fetu
lead
apron
arrowhead
also
reduc
fetal
radiat
exposur
b
axial
chest
ct
pulmonari
angiogram
obtain
manual
reduct
tube
current
tube
voltag
show
excel
vascular
opacif
provid
highqual
assess
pulmonari
embol
thorac
disord
matern
breast
shield
arrowhead
also
place
shield
select
filter
lowenergi
xray
photon
would
otherwis
deposit
preferenti
matern
breast
tissu
significantli
contribut
matern
breast
radiat
exposur
major
caus
matern
morbid
mortal
increas
intraabdomin
pressur
due
gravid
uteru
inhibitori
effect
progesteron
tone
esophag
sphincter
assumpt
supin
posit
deliveri
contribut
eat
labor
increas
volum
emesi
aspir
gastric
content
ph
lower
known
caus
chemic
pneumon
increas
permeabl
edema
mendelson
origin
report
today
two
third
case
aspir
take
place
deliveri
suit
emerg
endotrach
intub
patient
obstetr
crise
particularli
difficult
intub
deliveri
suit
fail
rate
eight
time
gener
surgic
popul
minim
chanc
acid
aspir
intub
oral
administr
blocker
antacid
intub
conjunct
formal
airway
assess
desir
identifi
risk
factor
intub
includ
high
mallampati
class
indic
poor
visibl
posterior
pharynx
short
neck
protrud
maxillari
incisor
reced
mandibl
ard
common
pregnanc
gener
popul
incid
deliveri
one
obstetr
intens
care
unit
ard
lead
caus
matern
death
period
three
common
nonobstetr
caus
pneumonia
sepsi
aspir
influenza
epidem
result
signific
increas
incid
ard
pregnanc
gener
numer
public
epidemiolog
manag
issu
australian
investig
describ
seri
pregnant
women
treat
extracorpor
membran
oxygen
reason
outcom
common
obstetr
caus
ard
includ
chorioamnion
amniot
fluid
embol
see
fig
trophoblast
embol
ventil
manag
unalt
pregnanc
although
pregnanc
exclus
criterion
ard
network
studi
clear
benefit
nonpregn
patient
support
use
anaphylactoid
syndrom
pregnanc
small
studi
demonstr
evid
mast
cell
degranul
suggest
role
complement
activ
imag
studi
affect
patient
usual
develop
bilater
parenchym
opac
consist
pulmonari
edema
associ
increas
permeabl
lung
injuri
fig
treatment
consist
support
care
associ
dissemin
intravascular
coagul
left
ventricular
respiratori
failur
fetu
promptli
deliv
case
matern
demis
emerg
postmortem
periresuscit
cesarean
section
warrant
instanc
cardiopulmonari
resuscit
pregnanc
pulmonari
arterioven
malform
may
expand
pregnanc
hormon
chang
increas
blood
volum
venou
distens
increas
likelihood
bleed
lifethreaten
complic
pregnant
women
hereditari
hemorrhag
telangiectasia
embol
surgic
manag
util
success
pregnanc
occasion
venou
air
embol
happen
pregnanc
presum
subplacent
venou
sinus
disord
clearli
document
labor
deliveri
cesarean
section
abort
patient
placenta
previa
engag
orogenit
sex
pregnanc
earli
puerperium
sinc
mendelson
origin
report
case
gastric
aspir
deliveri
incid
aspir
continu
lillington
colleagu
introduc
term
catameni
pneumothorax
describ
alreadi
report
phenomenon
spontan
pneumothorax
within
hour
onset
mens
appear
account
spontan
pneumothorac
women
often
affect
women
third
fourth
decad
life
case
attribut
thorac
endometriosi
judg
inspect
thoracotomi
fig
case
obscur
etiolog
howev
number
theori
advanc
first
theori
menstruat
absenc
normal
cervic
mucu
plug
permit
open
connect
ambient
air
abdomin
caviti
uteru
fallopian
tube
air
move
transdiaphragmat
rightsid
diaphragmat
fenestr
pleural
space
sometim
abdomin
laparoscopi
account
condit
rightsid
predomin
second
theori
high
level
prostaglandin
f
menstruat
caus
bronchospasm
attend
air
trap
pneumothorax
wheez
common
symptom
disord
third
theori
pleural
bleb
bulla
suscept
ruptur
menstruat
hormon
chang
viscer
pleural
leak
rare
found
surgeri
see
also
chapter
full
discuss
case
endometriosisassoci
pneumothorax
trial
gonadotropinreleas
hormon
warrant
phenomenon
repetit
lifethreaten
oral
contracept
progest
agent
tubal
lowvolum
ventilatori
strategi
pregnant
patient
tidal
volum
mlkg
base
patient
ideal
weight
prognosi
also
appear
similar
nonpregn
patient
although
ard
outcom
depend
underli
etiolog
pregnanc
may
complic
obstruct
sleep
apnea
osa
potenti
advers
affect
mother
fetu
although
upper
airway
edema
may
potenti
obstruct
event
apnea
hypopnea
uncommon
pregnanc
respiratori
stimulatori
effect
progesteron
osa
usual
develop
obes
patient
precipit
airway
mucos
edema
vascular
congest
accompani
pregnanc
osa
associ
preeclampsia
gestat
diabet
nocturn
hypoxemia
may
produc
poor
fetal
growth
although
snore
alon
associ
fetal
risk
pregnant
women
document
obstruct
sleep
apnea
increas
risk
develop
preeclampsia
preterm
birth
treatment
nasal
continu
posit
airway
pressur
safe
effect
women
document
signific
osa
interstiti
lung
diseas
usual
seen
patient
older
childbear
year
interstiti
diseas
exist
pregnant
women
reduc
diffus
capac
may
caus
difficulti
meet
increas
oxygen
consumpt
requir
pregnanc
associ
pulmonari
hypertens
regardless
caus
carri
signific
risk
cardiac
output
increas
pregnanc
data
exist
manag
outcom
patient
restrict
lung
diseas
appear
reason
well
toler
pregnanc
lymphangioleiomyomatosi
system
lupu
erythematosu
may
worsen
result
pregnanc
drug
therapi
use
interstiti
lung
diseas
may
accept
pregnanc
eg
prednison
azathioprin
therapi
eg
cyclophosphamid
rituximab
mycophenol
mofetil
usual
avoid
pleural
effus
may
accompani
obstetr
complic
preeclampsia
choriocarcinoma
mani
women
normal
pregnanc
develop
small
asymptomat
pleural
effus
postpartum
period
develop
result
increas
blood
volum
reduc
colloid
osmot
pressur
pregnanc
well
impair
lymphat
drainag
due
repeat
valsalva
maneuv
labor
moderates
effus
presenc
symptom
prompt
full
clinic
evalu
valsalva
maneuv
labor
may
also
produc
spontan
pneumothorax
pneumomediastinum
particularli
patient
predispos
condit
asthma
diagnosi
consid
women
develop
chest
discomfort
dyspnea
immedi
follow
deliveri
rosi
convent
therapi
includ
oophorectomi
progest
agent
mainli
medroxyprogesteron
acet
lung
transplant
perform
patient
disord
clearli
recur
sirolimu
trial
patient
angiomyolipoma
tuber
sclerosi
complex
lam
show
amelior
effect
lung
function
volum
angiomyolipoma
presum
suppress
signal
pathway
involv
product
defect
gene
lam
includ
group
perivascular
epithelioid
cell
tumor
whose
molecular
patholog
elucid
open
possibl
target
therapi
trophoblast
embol
rare
complic
hydatidiform
mole
abnorm
type
pregnanc
nonviabl
fertil
tissu
grow
uteru
one
seri
patient
hydatidiform
mole
embol
event
episod
respiratori
distress
patient
caus
embol
event
rather
pulmonari
edema
anemia
anoth
complic
event
embol
happen
common
time
evacu
mole
chorion
neoplasm
aris
gestat
suggest
larg
discrep
gestat
date
uterin
size
evalu
transvagin
ultrasonographi
use
exogen
gonadotrophin
stimul
ovul
vitro
fertil
associ
pulmonari
complic
ovarian
hyperstimul
syndrom
usual
manifest
ovarian
cyst
bilater
pleural
effus
ascit
intravascular
volum
deplet
hypovolem
shock
renal
failur
ard
may
result
pulmonari
embol
upper
limb
superior
venal
caval
thrombosi
may
result
hypercoagul
state
induc
estrogen
intravascular
volum
deplet
mechan
effus
unclear
like
relat
increas
permeabl
due
releas
vasoact
mediat
vascular
endotheli
growth
factor
appear
import
evid
point
mutat
folliclestimul
hormon
receptor
etiolog
least
case
treatment
support
involv
maintain
intravascular
volum
thoracentesi
requir
respiratori
compromis
abund
pleural
effus
thromboprophylaxi
normal
pregnanc
associ
profound
alter
respiratori
cardiovascular
physiolog
whichalthough
design
matern
fetal
wellbeingmay
exacerb
underli
cardiopulmonari
condit
caus
new
one
major
physiolog
perturb
found
normal
pregnanc
includ
increas
central
drive
breath
result
chang
pco
mm
hg
ph
increas
ligat
also
use
success
case
clearli
associ
system
endometriosi
thoracoscopi
menstruat
serv
defin
etiolog
use
achiev
pleurodesi
endometriosi
probabl
affect
women
show
clear
ethnic
differ
preval
commonli
diagnos
year
age
although
pelvic
pain
dysmenorrhea
infertil
predomin
manifest
atyp
locat
includ
diaphragmat
pleural
endobronchi
site
document
describ
previous
endometriosi
result
recurr
catameni
pneumothorax
common
thorac
present
see
fig
one
review
case
thorac
endometriosi
catameni
pneumothorax
present
symptom
case
follow
hemothorax
hemoptysi
also
associ
rightsid
pleural
pain
pleurit
effus
hemothorax
inspect
thoracotomi
thoracoscopi
typic
reveal
bluebrown
nodul
pleural
surfac
sometim
gunshot
distribut
absenc
known
pelvic
endometriosi
exclud
diagnosi
patient
associ
pelvic
diseas
diagnosi
suspect
clinic
ground
neither
ct
endoscopi
specif
rare
endometriosi
deposit
found
lung
parenchyma
account
catameni
hemoptysi
pleural
diaphragmat
diseas
thought
aris
transdiaphragmat
spread
retrograd
mens
even
abdomin
diseas
evid
massiv
ascit
sometim
relat
although
case
report
pneumothorac
may
attribut
cyclic
slough
tissu
key
surfac
viscer
pleura
air
trap
airway
involv
compress
pulmonari
parenchym
diseas
may
embol
origin
presum
case
central
nervou
system
endometriosi
diagnosi
establish
biopsi
show
characterist
ectop
endometri
gland
involv
site
medic
therapi
consist
progest
agent
gonadotropinreleas
hormon
surgic
approach
includ
excis
local
laser
ablat
pleurodesi
lymphangioleiomyomatosi
lam
rare
disord
afflict
predominantli
premenopaus
women
common
present
event
pneumothorax
report
patient
nation
heart
lung
blood
institut
registri
fundament
disord
smooth
muscl
prolifer
result
function
obstruct
vessel
lymphat
airway
see
chapter
complet
discuss
lam
involv
pulmonari
vascular
structur
respons
hemoptysi
wherea
lymphat
obstruct
account
chylou
effus
mediastin
retroperiton
lymphat
prolifer
may
featur
diseas
well
lam
also
associ
renal
angiomyolipoma
anoth
hamartomat
disord
tuber
sclematern
blood
volum
l
cardiac
output
week
gestat
common
pulmonari
disord
pregnanc
asthma
effect
pregnanc
asthma
variabl
worsen
improv
remain
unchang
roughli
one
third
afflict
women
risk
poorli
control
asthma
mother
fetu
pregnanc
far
outweigh
risk
drug
therapi
standard
drug
safer
other
see
tabl
select
whenev
possibl
cystic
fibrosi
infecti
pneumonia
link
advers
fetal
matern
outcom
risk
depend
larg
sever
complic
disord
prepregn
counsel
avoid
certain
antimicrobi
drug
note
tabl
strongli
recommend
pulmonari
edema
may
develop
pregnanc
women
underli
heart
diseas
especi
valvular
stenosi
cardiomyopathi
preeclampsia
caus
mechan
differ
specif
therapi
pulmonari
embol
lead
caus
matern
mortal
indic
pregnanc
lowmolecularweight
heparin
safe
treatment
prevent
warfarin
contraind
ventilationperfus
imag
ct
pulmonari
angiographi
magnet
reson
imag
use
need
